329 related articles for article (PubMed ID: 36472070)
1. Association between Sarcopenic Obesity Status and Nonalcoholic Fatty Liver Disease and Fibrosis.
Song W; Yoo SH; Jang J; Baik SJ; Lee BK; Lee HW; Park JS
Gut Liver; 2023 Jan; 17(1):130-138. PubMed ID: 36472070
[TBL] [Abstract][Full Text] [Related]
2. Association between Sarcopenic Obesity and Nonalcoholic Fatty Liver Disease and Fibrosis detected by Fibroscan.
Wijarnpreecha K; Aby ES; Ahmed A; Kim D
J Gastrointestin Liver Dis; 2021 Jun; 30(2):227-232. PubMed ID: 33951121
[TBL] [Abstract][Full Text] [Related]
3. Risk Stratification for Sarcopenic Obesity in Subjects With Nonalcoholic Fatty Liver Disease.
Chun HS; Lee M; Lee HA; Lee S; Kim S; Jung YJ; Lee C; Kim H; Lee HA; Kim HY; Yoo K; Kim TH; Ahn SH; Kim SU
Clin Gastroenterol Hepatol; 2023 Aug; 21(9):2298-2307.e18. PubMed ID: 36462755
[TBL] [Abstract][Full Text] [Related]
4. A significant association of non-obese non-alcoholic fatty liver disease with sarcopenic obesity.
Kashiwagi K; Takayama M; Fukuhara K; Shimizu-Hirota R; Chu PS; Nakamoto N; Inoue N; Iwao Y; Kanai T
Clin Nutr ESPEN; 2020 Aug; 38():86-93. PubMed ID: 32690183
[TBL] [Abstract][Full Text] [Related]
5. Sarcopenia Among Patients With Nonalcoholic Fatty Liver Disease (NAFLD) Is Associated With Advanced Fibrosis.
Harring M; Golabi P; Paik JM; Shah D; Racila A; Cable R; Srishord M; Younossi ZM
Clin Gastroenterol Hepatol; 2023 Oct; 21(11):2876-2888.e5. PubMed ID: 36848980
[TBL] [Abstract][Full Text] [Related]
6. Association of Physical Activity With Risk of Liver Fibrosis, Sarcopenia, and Cardiovascular Disease in Nonalcoholic Fatty Liver Disease.
Chun HS; Lee M; Lee HA; Oh SY; Baek HJ; Moon JW; Kim YJ; Lee J; Kim H; Kim HY; Yoo K; Kim TH; Kim SU
Clin Gastroenterol Hepatol; 2023 Feb; 21(2):358-369.e12. PubMed ID: 34998993
[TBL] [Abstract][Full Text] [Related]
7. Low muscle mass and low muscle strength associate with nonalcoholic fatty liver disease.
Gan D; Wang L; Jia M; Ru Y; Ma Y; Zheng W; Zhao X; Yang F; Wang T; Mu Y; Zhu S
Clin Nutr; 2020 Apr; 39(4):1124-1130. PubMed ID: 31053512
[TBL] [Abstract][Full Text] [Related]
8. Appendicular Skeletal Muscle Mass to Visceral Fat Area Ratio Predicts Hepatic Morbidities.
Han E; Lee YH; Ahn SH; Cha BS; Kim SU; Lee BW
Gut Liver; 2024 May; 18(3):509-519. PubMed ID: 38013477
[TBL] [Abstract][Full Text] [Related]
9. The Association of Sarcopenia and Visceral Obesity with Lean Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus.
Zhang X; He Z; Si Q; Hu X; Yang L; Gu X; Du L; Wang L; Pan L; Li Y; Li J; Yang B; Gu X
J Diabetes Res; 2022; 2022():2229139. PubMed ID: 36387941
[TBL] [Abstract][Full Text] [Related]
10. Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA.
Wijarnpreecha K; Kim D; Raymond P; Scribani M; Ahmed A
Eur J Gastroenterol Hepatol; 2019 Sep; 31(9):1121-1128. PubMed ID: 30888971
[TBL] [Abstract][Full Text] [Related]
11. Skeletal muscle mass and abdominal obesity are independent predictors of hepatic steatosis and interact to predict ten-year cardiovascular disease incidence: Data from the ATTICA cohort study.
Kouvari M; Polyzos SA; Chrysohoou C; Skoumas J; Pitsavos CS; Panagiotakos DB; Mantzoros CS
Clin Nutr; 2022 Jun; 41(6):1281-1289. PubMed ID: 35504171
[TBL] [Abstract][Full Text] [Related]
12. Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease.
Petta S; Ciminnisi S; Di Marco V; Cabibi D; Cammà C; Licata A; Marchesini G; Craxì A
Aliment Pharmacol Ther; 2017 Feb; 45(4):510-518. PubMed ID: 28028821
[TBL] [Abstract][Full Text] [Related]
13. Presence of sarcopenia identifies a special group of lean NAFLD in middle-aged and older people.
Zhu X; Huang Q; Ma S; Chen L; Wu Q; Wu L; Ma H; Li X; Li Q; Aleteng Q; Hu Y; He W; Gao J; Lin H; Tang H; Gao X; Xia M
Hepatol Int; 2023 Apr; 17(2):313-325. PubMed ID: 36327053
[TBL] [Abstract][Full Text] [Related]
14. Age-Related Decrease in Skeletal Muscle Mass Is an Independent Risk Factor for Incident Nonalcoholic Fatty Liver Disease: A 10-Year Retrospective Cohort Study.
Lee MJ; Kim EH; Bae SJ; Kim GA; Park SW; Choe J; Jung CH; Lee WJ; Kim HK
Gut Liver; 2019 Jan; 13(1):67-76. PubMed ID: 30037166
[TBL] [Abstract][Full Text] [Related]
15. Risk stratification using sarcopenia status among subjects with metabolic dysfunction-associated fatty liver disease.
Chun HS; Kim MN; Lee JS; Lee HW; Kim BK; Park JY; Kim DY; Ahn SH; Kim SU
J Cachexia Sarcopenia Muscle; 2021 Oct; 12(5):1168-1178. PubMed ID: 34337887
[TBL] [Abstract][Full Text] [Related]
16. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011).
Lee YH; Kim SU; Song K; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Han KH
Hepatology; 2016 Mar; 63(3):776-86. PubMed ID: 26638128
[TBL] [Abstract][Full Text] [Related]
17. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis.
Koo BK; Kim D; Joo SK; Kim JH; Chang MS; Kim BG; Lee KL; Kim W
J Hepatol; 2017 Jan; 66(1):123-131. PubMed ID: 27599824
[TBL] [Abstract][Full Text] [Related]
18. Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity.
Kim HK; Bae SJ; Lee MJ; Kim EH; Park H; Kim HS; Cho YK; Jung CH; Lee WJ; Choe J
Clin Mol Hepatol; 2023 Oct; 29(4):987-1001. PubMed ID: 37403320
[TBL] [Abstract][Full Text] [Related]
19. Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B.
Han E; Lee YH; Kim BK; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Han KH; Kim SU
Aliment Pharmacol Ther; 2018 Aug; 48(3):300-312. PubMed ID: 29920701
[TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic fatty liver disease in the over-60s: Impact of sarcopenia and obesity.
Wijarnpreecha K; Panjawatanan P; Aby E; Ahmed A; Kim D
Maturitas; 2019 Jun; 124():48-54. PubMed ID: 31097179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
